The First Deuterated Drug Arrives
Seeking Alpha | April 05, 2017
The first deuterated drug has finally been approved by the FDA. It’s Austedo (deutetrabenazine), from Teva (NYSE:TEVA), and it targets Huntington’s chorea. This is an interesting development on several levels.